HN1999000141A - Procedimiento para preparar sales de trovafloxacina de adicion de acidos. - Google Patents

Procedimiento para preparar sales de trovafloxacina de adicion de acidos.

Info

Publication number
HN1999000141A
HN1999000141A HN1999000141A HN1999000141A HN1999000141A HN 1999000141 A HN1999000141 A HN 1999000141A HN 1999000141 A HN1999000141 A HN 1999000141A HN 1999000141 A HN1999000141 A HN 1999000141A HN 1999000141 A HN1999000141 A HN 1999000141A
Authority
HN
Honduras
Prior art keywords
acids
procedure
addition
trovafloxacin
preparing salts
Prior art date
Application number
HN1999000141A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1999000141A publication Critical patent/HN1999000141A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA PREPARAR SALES TROVAFLOXACINA DE ADICION DE ACIDOS.
HN1999000141A 1998-09-03 1999-08-17 Procedimiento para preparar sales de trovafloxacina de adicion de acidos. HN1999000141A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
HN1999000141A true HN1999000141A (es) 2000-06-19

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000141A HN1999000141A (es) 1998-09-03 1999-08-17 Procedimiento para preparar sales de trovafloxacina de adicion de acidos.

Country Status (40)

Country Link
US (1) US6359137B1 (es)
EP (1) EP0989119A1 (es)
JP (1) JP3354526B2 (es)
KR (1) KR20000022858A (es)
CN (1) CN1248580A (es)
AP (1) AP1118A (es)
AR (1) AR021475A1 (es)
AU (1) AU761035B2 (es)
BG (1) BG103703A (es)
BR (1) BR9904082A (es)
CA (1) CA2281244C (es)
CO (1) CO5251466A1 (es)
EA (1) EA002340B1 (es)
EE (1) EE04118B1 (es)
GE (1) GEP20022785B (es)
GT (1) GT199900142A (es)
HN (1) HN1999000141A (es)
HR (1) HRP990274A2 (es)
HU (1) HUP9902967A3 (es)
ID (1) ID23718A (es)
IL (1) IL131614A0 (es)
IN (1) IN191583B (es)
IS (1) IS5168A (es)
MA (1) MA24966A1 (es)
MY (1) MY130800A (es)
NO (1) NO994261L (es)
NZ (1) NZ337605A (es)
OA (1) OA11152A (es)
PA (1) PA8481001A1 (es)
PE (1) PE20001026A1 (es)
PL (1) PL335246A1 (es)
SG (1) SG74748A1 (es)
SK (1) SK116599A3 (es)
SV (1) SV1999000144A (es)
TN (1) TNSN99164A1 (es)
TR (1) TR199902138A2 (es)
TW (1) TW520369B (es)
UY (1) UY25686A1 (es)
YU (1) YU43199A (es)
ZA (1) ZA995630B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
WO1995019361A1 (en) * 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
SK280535B6 (sk) * 1995-06-06 2000-03-13 Pfizer Inc. Kryštalická forma bezvodej soli kyseliny 7-([1a,5a
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
AU704115B2 (en) * 1995-08-29 1999-04-15 Pfizer Inc. Zwitterionic forms of trovafloxacin
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
EP0989119A1 (en) 2000-03-29
JP2000086658A (ja) 2000-03-28
AU4482699A (en) 2000-03-16
TR199902138A2 (xx) 2000-04-21
SV1999000144A (es) 2000-09-05
EA199900708A3 (ru) 2000-08-28
JP3354526B2 (ja) 2002-12-09
PE20001026A1 (es) 2000-10-11
CO5251466A1 (es) 2003-02-28
CA2281244C (en) 2003-05-20
AR021475A1 (es) 2002-07-24
MY130800A (en) 2007-07-31
TNSN99164A1 (fr) 2005-11-10
HU9902967D0 (en) 1999-10-28
HUP9902967A2 (hu) 2000-05-28
IN191583B (es) 2003-12-06
HRP990274A2 (en) 2000-10-31
NO994261L (no) 2000-03-06
GEP20022785B (en) 2002-09-25
AP1118A (en) 2002-11-21
UY25686A1 (es) 2000-03-31
HUP9902967A3 (en) 2000-11-28
GT199900142A (es) 2001-02-15
US6359137B1 (en) 2002-03-19
NZ337605A (en) 2001-03-30
NO994261D0 (no) 1999-09-02
CA2281244A1 (en) 2000-03-03
EE04118B1 (et) 2003-08-15
CN1248580A (zh) 2000-03-29
ID23718A (id) 2000-05-11
EA002340B1 (ru) 2002-04-25
EE9900457A (et) 2000-04-17
SG74748A1 (en) 2000-08-22
PL335246A1 (en) 2000-03-13
PA8481001A1 (es) 2000-09-29
TW520369B (en) 2003-02-11
IL131614A0 (en) 2001-01-28
YU43199A (sh) 2002-11-15
SK116599A3 (en) 2000-05-16
BR9904082A (pt) 2000-09-12
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
IS5168A (is) 2000-03-04
EA199900708A2 (ru) 2000-04-24
AU761035B2 (en) 2003-05-29
BG103703A (bg) 2001-08-31
AP9901667A0 (en) 1999-12-31
MA24966A1 (fr) 2000-04-01
ZA995630B (en) 2001-03-01

Similar Documents

Publication Publication Date Title
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1996000101A (es) Terapia combinada para la osteoporosis
HN1998000057A (es) Derivados de nicotinamida
HN1999000066A (es) Formulaciones farmaceuticas
ECSP034437A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
HN1997000149A (es) Derivados de 6 fenilpiridil 2 amina
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
HN1998003689A (es) Azetidinas
HN2000000031A (es) Inhibidores de acido abierto y sales de dihidrolixilo de redustosa hmg-co-a.
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
HN1998000167A (es) Nuevo procedimiento para preparar una cetoimina
HN1997000127A (es) Procedimiento e intermedios para preparar derivados de cromanol sustituidos.
HN1998000199A (es) Agentes terapeuticos
HN1999000141A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
ES2169481T3 (es) Procedimientos e intermedios utiles para preparar antifolatos.
HN1999000043A (es) Procedimiento para alquilar sulfonamidas impedidas estericamente.
HN1998000102A (es) Composiciones solubilizadas de sertralina